Table 4.
Univariate and Multivariate Cox Proportional Analyses of Prognostic Factors Associated with Recurrence-Free Survival in NSCLC Patients
| Variables | Univariate | Multivariate | ||
|---|---|---|---|---|
| HR (95% CI) | P-value | HR (95% CI) | P-value | |
| Age, ≥55 vs <55 | 1.004 (0.894–1.311) | 0.263 | ||
| Sex, male vs female | 0.999 (0.992–1.009) | 0.687 | ||
| Smoking status, smoker vs non-smoker | 1.312 (0.893–1.934) | 0.374 | ||
| Histology | ||||
| Adenocarcinoma vs squamous cell carcinoma | 1.007 (0.912–1.174) | 0.155 | ||
| Adenocarcinoma vs large cell carcinoma | 1.004 (0.941–1.319) | 0.374 | ||
| TNM stage, II vs I | 2.756 (1.632–3.213) | 0.001* | 2.274 (1.127–3.017) | 0.002* |
| Tumor size, ≥3 vs <3 | 1.456 (0.724–2.074) | 0.163 | ||
| Lymph node metastasis, yes vs no | 2.121 (1.274–3.019) | 0.003* | 2.093 (1.176–2.875) | 0.005* |
| SLC9A3-AS1 expression, high vs low | 1.456 (1.115–2.174) | 0.004* | 1.374 (1.009–1.864) | 0.014* |
Note: *P <0.05.
Abbreviations: NSCLC, non-small-cell lung cancer; HR, hazard ratio; CI, confidence interval.